Nasdaq:US$16.36 (-0.09) | HKEX:HK$25.90 (-0.20) | AIM:£2.66 (-0.05)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 1 Apr 2014

AACR 2014: Anti-tumour activity of Epitinib in patient derived esophagus cancer models